{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:47:47Z","timestamp":1777463267030,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.clinbiochem.2014.08.016","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T16:00:12Z","timestamp":1409414412000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: Correlation with systemic inflammatory markers and oxidative stress, preliminary report"],"prefix":"10.1016","volume":"48","author":[{"given":"Shiva","family":"Shahmohamadnejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Vaisi-Raygani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadola","family":"Shakiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariborz","family":"Bahrehmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahimi","family":"Shakiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayehbeh","family":"Pourmotabbed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clinbiochem.2014.08.016_bb0005","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/acr.20288","article-title":"Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodies","volume":"62","author":"Guzian","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0010","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1126\/science.270.5241.1500","article-title":"Definition of two angiogenic pathways by distinct alpha v integrins","volume":"270","author":"Friedlander","year":"1995","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.clinbiochem.2014.08.016_bb0015","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.freeradbiomed.2004.07.034","article-title":"Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?","volume":"37","author":"Mackness","year":"2004","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.clinbiochem.2014.08.016_bb0020","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00109-003-0481-4","article-title":"Paraoxonase gene polymorphisms, oxidative stress, and diseases","volume":"81","author":"Li","year":"2003","journal-title":"J Mol Med"},{"issue":"11","key":"10.1016\/j.clinbiochem.2014.08.016_bb0025","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.38118","article-title":"Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis","volume":"65","author":"Charles-Schoeman","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0030","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2169\/internalmedicine.46.0049","article-title":"Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance","volume":"46","author":"Iwasaki","year":"2007","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.clinbiochem.2014.08.016_bb0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/0961203313518622","article-title":"Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report","volume":"23","author":"Bahrehmand","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0040","first-page":"1","article-title":"Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran","volume":"12","author":"Vaisi-Raygani","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clinbiochem.2008.10.025","article-title":"Serum butyrylcholinesterase activity andphenotype associations with lipid profile in stroke patients","volume":"42","author":"Vaisi-Raygani","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0050","first-page":"52","article-title":"Characterization of 12 silent alleles of the human butyrylcholinesterase (BUCHE) gene","volume":"58","author":"Primo-Parmo","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0055","first-page":"214","article-title":"Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation","volume":"13","author":"Das","year":"2007","journal-title":"Med Sci Monit"},{"issue":"6","key":"10.1016\/j.clinbiochem.2014.08.016_bb0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1539\/joh.O10017","article-title":"Paraoxonase 1 correlates with butyrylcholinesterase and gamma glutamyl transferase in workers chronically exposed to pesticides","volume":"52","author":"Araoud","year":"2010","journal-title":"J Occup Health"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0065","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.lfs.2004.02.019","article-title":"Increased seum butyrylcholinesterase activity in type IIb hyperlipidaemic patients","volume":"75","author":"Kalman","year":"2004","journal-title":"Life Sci"},{"issue":"16","key":"10.1016\/j.clinbiochem.2014.08.016_bb0070","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3109\/14767058.2013.795534","article-title":"Butyrylcholinesterase (BChE) activity is associated with the risk of preeclampsia: influence on lipid and lipoprotein metabolism and oxidative stress","volume":"26","author":"Rahimi","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0075","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.ATV.21.4.542","article-title":"Human paraoxonase-3 is an HDL associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids","volume":"21","author":"Reddy","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI119134","article-title":"Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes","volume":"99","author":"Blatter Garin","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1357-4310(99)01546-4","article-title":"Does paraoxonase play a role in susceptibility to cardiovascular disease?","volume":"5","author":"Aviram","year":"1999","journal-title":"Mol Med Today"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0090","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2337\/diabetes.48.3.623","article-title":"Paraoxonase 192 Gln\/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes","volume":"48","author":"Pfohl","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0095","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3346\/jkms.2011.26.6.720","article-title":"Effects of intronic and exonic polymorphisms of paraoxonase 1 (PON1) gene on serum PON1 activity in a Korean population","volume":"26","author":"Eom","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0100","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.clinbiochem.2009.02.017","article-title":"Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome","volume":"42","author":"Koubaa","year":"2009","journal-title":"Clin Biochem"},{"issue":"8","key":"10.1016\/j.clinbiochem.2014.08.016_bb0105","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1007\/s11033-011-0696-3","article-title":"Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease","volume":"38","author":"Vaisi-Raygani","year":"2011","journal-title":"Mol Biol Rep"},{"issue":"3","key":"10.1016\/j.clinbiochem.2014.08.016_bb0110","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4238\/vol9-3gmr893","article-title":"The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis","volume":"9","author":"Hashemi","year":"2010","journal-title":"Genet Mol Res"},{"issue":"11","key":"10.1016\/j.clinbiochem.2014.08.016_bb0115","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0125","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/0961203312436857","article-title":"Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients","volume":"21","author":"Bahrehmand","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng0193-73","article-title":"The molecular basis of the human serum paraoxonase activity polymorphism","volume":"3","author":"Humbert","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0135","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2133.2012.11170.x","article-title":"Paraoxonase (PON1) 55 polymorphism, lipid profiles and psoriasis","volume":"167","author":"Asefi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0140","series-title":"Cholinesterase monographs in humans","first-page":"1","author":"Whittaker","year":"1986"},{"issue":"10","key":"10.1016\/j.clinbiochem.2014.08.016_bb0145","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1089\/dna.2012.1631","article-title":"Polymorphisms in genes involved in oxidative stress response in patients with sudden sensorineural hearing loss and M\u00e9ni\u00e8re's disease in a Japanese population","volume":"31","author":"Teranishi","year":"2012","journal-title":"DNA Cell Biol"},{"issue":"7","key":"10.1016\/j.clinbiochem.2014.08.016_bb0150","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/art.11078","article-title":"Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects","volume":"48","author":"del","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.clinbiochem.2014.08.016_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0160","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00109-007-0226-x","article-title":"Cholinergic status modulations in human volunteers under acute inflammation","volume":"85","author":"Ofek","year":"2007","journal-title":"J Mol Med"},{"issue":"24","key":"10.1016\/j.clinbiochem.2014.08.016_bb0165","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.clinbiochem.2014.08.016_bb0170","first-page":"906","article-title":"Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964\u201395","volume":"29","author":"Bjornadal","year":"2002","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.clinbiochem.2014.08.016_bb0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.clinbiochem.2014.08.016_bb0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa072366","article-title":"Genome-wide association analysis of coronary artery disease","volume":"357","author":"Samani","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.clinbiochem.2014.08.016_bb0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMe078121","article-title":"Scanning the genome for coronary risk","volume":"357","author":"Rosenzweig","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinbiochem.2014.08.016_bb0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4238\/vol9-1gmr728","article-title":"Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran","volume":"9","author":"Hashemi","year":"2010","journal-title":"Genet Mol Res"},{"issue":"11","key":"10.1016\/j.clinbiochem.2014.08.016_bb0195","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1194\/jlr.M600297-JLR200","article-title":"The 192R\/Q polymorphs of serum paraoxonase PON1differ in HDL binding, lipolactonase stimulation, and cholesterol efflux","volume":"47","author":"Gaidukov","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0200","doi-asserted-by":"crossref","first-page":"44444","DOI":"10.1074\/jbc.M105660200","article-title":"Paraoxonase-2 is a ubiquitously expressed pro-tein with antioxidant properties and is capable of preventing cell-medi-ated oxidative modification of low density lipoprotein","volume":"276","author":"Ng","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumu-lation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0021-9150(93)90183-U","article-title":"Protection of low-den-sity lipoprotein against oxidative modification by high-density lipopro-tein associated paraoxonase","volume":"104","author":"Mackness","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0215","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipo-protein oxidation and preserves its functions: a possible peroxi-dative role for PON1","volume":"101","author":"Aviram","year":"1998","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.clinbiochem.2014.08.016_bb0220","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1530\/EJE-09-0732","article-title":"Nondiabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation","volume":"162","author":"Tabur","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clinbiochem.2014.08.016_bb0225","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.med.54.101601.152421","article-title":"Functional genomic of the paraxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardio-vascular disease, and drug metabolism","volume":"54","author":"Costa","year":"2003","journal-title":"Annu Rev Med"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014006511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014006511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:45:08Z","timestamp":1757864708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912014006511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0009912014006511"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.08.016","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: Correlation with systemic inflammatory markers and oxidative stress, preliminary report","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}